Kiniksa Pharmaceuticals International, plc Class A Stock Performance

Open $76.91	Prev. Close $77.80	Circuit Range N/A
Day Range $75.63 - $78.70	Year Range $35.66 - $82.65	Volume 43,456
Average Traded $77.43

Kiniksa Pharmaceuticals International, plc Class A Share Price Today

As of 9 October 2026, Kiniksa Pharmaceuticals International, plc Class A's share price is $78.76. The stock opened at $76.91, compared to its previous close of $77.80. During today's trading session, Kiniksa Pharmaceuticals International, plc Class A's share price traded between $75.63 and $78.70, with an average price of $77.16. Over the past 52 weeks, the stock has recorded a high of $82.65 and a low of $35.66. In terms of performance, Kiniksa Pharmaceuticals International, plc Class A's share price has risen by 46.56% over the last six months and is up 113.10% on a year-on-year basis.

Kiniksa Pharmaceuticals International, plc Class A Share Price Chart

$75.63$78.70

Kiniksa Pharmaceuticals International, plc Class A Stock Fundamentals & Key Indicators

Market Cap $5.84B	PE Ratio (TTM) 76.18	Dividend Yield 0.39%
EPS (TTM) $1.03	Revenue (TTM) $677.56B	Return On Equity (TTM) 12.33%
Profit Margin 8.71%	Debt to Equity 0.13	Quarterly Earnings Growth YoY 37.91%

Kiniksa Pharmaceuticals International, plc Class A Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$180.86	$202.13	$214.27	$243.60
Net Profit	$18.44	$14.20	$22.59	$25.43
Net Profit Margin	10.20%	7.03%	10.54%	10.44%
Income Change	N/A	-22.99%	59.08%	12.57%

Kiniksa Pharmaceuticals International, plc Class A Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$220.18	$270.26	$423.24	$677.56
Net Profit	$183.36	$14.08	-$43.19	$59.01
Net Profit Margin	83.28%	5.21%	-10.20%	8.71%
Income Change	N/A	-92.32%	-406.75%	236.63%

About Kiniksa Pharmaceuticals International, plc Class A

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Kiniksa Pharmaceuticals International, plc Class A Historical Returns

Month	Open	Close	Change %
Oct 2026	$73.87	$78.65	+5.34%
Sep 2026	$78.93	$74.66	-6.34%
Aug 2026	$73.19	$79.71	+7.14%
Jul 2026	$63.51	$74.40	+16.40%
Jun 2026	$47.66	$63.92	+32.09%
May 2026	$53.38	$48.39	-9.96%
Apr 2026	$48.90	$53.74	+11.29%
Mar 2026	$44.13	$48.29	+8.50%
Feb 2026	$43.84	$44.51	+1.40%
Jan 2026	$41.50	$43.89	+6.58%
Dec 2025	$42.39	$41.18	-3.08%
Nov 2025	$37.48	$42.49	+14.96%

KNSA Share Price FAQs

What is Kiniksa Pharmaceuticals International, plc Class A share price today?

Kiniksa Pharmaceuticals International, plc Class A share price today is $78.76 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Kiniksa Pharmaceuticals International, plc Class A stock?

The 52 week high of Kiniksa Pharmaceuticals International, plc Class A stock is $82.65, while the 52 week low is $35.66 as of 9 Oct '26.

What is KNSA's market capitalisation today?

KNSA market capitalisation is $5.84B as of October 9, 2026, at 2:59 pm IST.

What is KNSA's net income for the last quarter?

KNSA's net income for the last quarter is 25.43B USD.

What is the 5 year returns of KNSA?

The 5 year returns of KNSA is 658.04% as on 9 Oct '26.

What is the high & low stock price of KNSA today?

KNSA stock price hit a high of $78.70 and low of $75.63 as of 9 Oct '26.

Can I buy KNSA shares in India?

Yes. You can buy KNSA in India by opening an international trading account.